Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Gobbi

Showing results (111-120 of 124) with videos related to

Pageof 13
Sort By:
Cartilage|January 17, 2020
Scaffolds for Knee Chondral and Osteochondral Defects: Indications for Different Clinical Scenarios. A Consensus StatementGiuseppe Filardo, Luca Andriolo, Peter Angele, et al.
Journal of Chemical Information and Modeling|November 26, 2022
Collaborative Assessment of Molecular Geometries and Energies from the Open Force FieldLorenzo D'Amore, David F Hahn, David L Dotson, et al.
Bioorganic & Medicinal Chemistry Letters|April 30, 2008
Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda6-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones: Part 4. Optimization of DMPK propertiesMaria V Sergeeva, Yuefen Zhou, Darian M Bartkowski, et al.
Bioorganic & Medicinal Chemistry Letters|December 3, 2014
A reversed sulfonamide series of selective RORc inverse agonistsMonique B van Niel, Benjamin P Fauber, Matthew Cartwright, et al.
ACS Medicinal Chemistry Letters|March 19, 2020
Discovery of Potent Benzolactam IRAK4 Inhibitors with Robust in Vivo ActivityNaomi S Rajapaksa, Alberto Gobbi, Joy Drobnick, et al.
Journal of Medicinal Chemistry|May 15, 2019
Development of Potent and Selective Pyrazolopyrimidine IRAK4 InhibitorsMarian C Bryan, Joy Drobnick, Alberto Gobbi, et al.
Journal of Medicinal Chemistry|March 29, 2021
Targeting KRAS Mutant Cancers via Combination Treatment: Discovery of a 5-Fluoro-4-(3<i>H</i>)-quinazolinone Aryl Urea pan-RAF Kinase InhibitorMalcolm P Huestis, Darlene Dela Cruz, Antonio G DiPasquale, et al.
Bioorganic & Medicinal Chemistry Letters|June 17, 2008
Structure-based design, synthesis, and biological evaluation of 1,1-dioxoisothiazole and benzo[b]thiophene-1,1-dioxide derivatives as novel inhibitors of hepatitis C virus NS5B polymeraseSun Hee Kim, Martin T Tran, Frank Ruebsam, et al.
Bioorganic & Medicinal Chemistry Letters|October 3, 2009
5,5'- and 6,6'-dialkyl-5,6-dihydro-1H-pyridin-2-ones as potent inhibitors of HCV NS5B polymeraseDavid A Ellis, Julie K Blazel, Chinh V Tran, et al.
Bioorganic & Medicinal Chemistry Letters|December 5, 2008
5,6-Dihydro-1H-pyridin-2-ones as potent inhibitors of HCV NS5B polymeraseFrank Ruebsam, Chinh V Tran, Lian-Sheng Li, et al.
Pageof 13

Showing results (111-120 of 124) with videos related to

Sort By:
Pageof 13
Cartilage|January 17, 2020
Scaffolds for Knee Chondral and Osteochondral Defects: Indications for Different Clinical Scenarios. A Consensus StatementGiuseppe Filardo, Luca Andriolo, Peter Angele, et al.
Journal of Chemical Information and Modeling|November 26, 2022
Collaborative Assessment of Molecular Geometries and Energies from the Open Force FieldLorenzo D'Amore, David F Hahn, David L Dotson, et al.
Bioorganic & Medicinal Chemistry Letters|April 30, 2008
Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda6-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones: Part 4. Optimization of DMPK propertiesMaria V Sergeeva, Yuefen Zhou, Darian M Bartkowski, et al.
Bioorganic & Medicinal Chemistry Letters|December 3, 2014
A reversed sulfonamide series of selective RORc inverse agonistsMonique B van Niel, Benjamin P Fauber, Matthew Cartwright, et al.
ACS Medicinal Chemistry Letters|March 19, 2020
Discovery of Potent Benzolactam IRAK4 Inhibitors with Robust in Vivo ActivityNaomi S Rajapaksa, Alberto Gobbi, Joy Drobnick, et al.
Journal of Medicinal Chemistry|May 15, 2019
Development of Potent and Selective Pyrazolopyrimidine IRAK4 InhibitorsMarian C Bryan, Joy Drobnick, Alberto Gobbi, et al.
Journal of Medicinal Chemistry|March 29, 2021
Targeting KRAS Mutant Cancers via Combination Treatment: Discovery of a 5-Fluoro-4-(3<i>H</i>)-quinazolinone Aryl Urea pan-RAF Kinase InhibitorMalcolm P Huestis, Darlene Dela Cruz, Antonio G DiPasquale, et al.
Bioorganic & Medicinal Chemistry Letters|June 17, 2008
Structure-based design, synthesis, and biological evaluation of 1,1-dioxoisothiazole and benzo[b]thiophene-1,1-dioxide derivatives as novel inhibitors of hepatitis C virus NS5B polymeraseSun Hee Kim, Martin T Tran, Frank Ruebsam, et al.
Bioorganic & Medicinal Chemistry Letters|October 3, 2009
5,5'- and 6,6'-dialkyl-5,6-dihydro-1H-pyridin-2-ones as potent inhibitors of HCV NS5B polymeraseDavid A Ellis, Julie K Blazel, Chinh V Tran, et al.
Bioorganic & Medicinal Chemistry Letters|December 5, 2008
5,6-Dihydro-1H-pyridin-2-ones as potent inhibitors of HCV NS5B polymeraseFrank Ruebsam, Chinh V Tran, Lian-Sheng Li, et al.
Pageof 13